Nov 21, 2017

According to the latest report, Japan’s drug delivery devices market, which was $2.56bn in 2016, is estimated to reach $3.4bn by 2023. The market is set to grow at a CAGR of 4.2% during the forecast period. The Drug delivery device is a diversified portfolio including central venous catheters, needle-free injections, infusion systems and metered dose inhaler devices.

Japan’s drug delivery devices market reported sales of 107.56 million units in 2009, In 2016, the market has seen continued growth in sales 40.20 million units increase in-addition to 2009 sale units to 140.76 million units and estimated to grow further with a CAGR of 4.7% through 2016-2023.

The market expects believes that Japan’s drug delivery devices market will expand due to several factors such as rise in chronic diseases, demand for controlled drug release and new technologies. Players have to closely watch out the prevailing and emerging market trends in this competitive drug delivery devices landscape to tap the myriad opportunities.

Infusion Systems segment dominates the market with 60% of the total market share in the country and trends show that its growth pace will further continue, at a CAGR of 4.7% during 2016-23.Despite the stiff competition, domestic players Terumo Corp and Nipro Corp enjoyed a combined market share of 30.5% in 2016.

In coming years, players in the infusion systems segment will invest in several strategies such as product launches, innovations, research and development, M&As to sustain in the competitive market.

Contents of the Report

  • Introduction
  • Drug Delivery Devices Market
  • Japan Central Venous Catheters Market
  • Japan Infusion Systems Market
  • Japan Metered Dose Inhaler
  • Devices Market
  • Japan Overview of Key Companies in Japan
  • Drug Delivery Devices Market
  • Financial Deals Landscape
  • Recent Developments
  • Appendix

Key benefits of buying this profile include:

The Japan Drug Delivery Devices Market report helps you to develop


  • Business strategies by identifying the key market categories poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “Japan Drug Delivery Devices Market Outlook to 2023” report

  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Hospira Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH
  • The GlobalData Differentiation

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

  • 15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries, from 2009 and forecast to 2023
  • 10,000+ primary interviews, conducted annually to ensure data and report quality
  • Approximately 4,000+ medical equipment conference reports, industry-leading analysis reports covering growing sectors, market trends, investment opportunities and competitive landscape
  • 600+ medical equipment trends and issues, and investment and M&A trends
  • 56,000+ medical equipment company profiles
  • 4,300+ company profiles of medical equipment manufacturers in China and India
  • 2,000+ company profiles of medical equipment manufacturers in Japan
  • 825+ companies’ revenue splits and market shares
  • 1,900+ quarterly and annual medical equipment company financials
  • 940+ medical equipment company SWOTs
  • 21,500+ pipeline product profiles
  • 34,500+ marketed product profiles
  • 36,000+ clinical trials
  • 36,500+ trial investigators
  • 20,600+ product patents
  • 3,700+ reports on companies with products in development
  • 21,500+ reports on deals in the medical equipment industry
  • 1,300+ surgical and diagnostic procedures by therapy area
  • 50+ key healthcare indicators by country

About GlobalData 

GlobalData is a leading provider of global business intelligence including market, competitor, and product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.

About is a syndicated report platform with wide variety of industry reports from reputed industry publishers. is promoted by DART Consulting. lists variety of reports at the best price with seasonal discounts and promotion codes.

This report is available at

Contact us:

Direct: + 91-80- 4224 7136, 953-807- 6063



Share :